199 related articles for article (PubMed ID: 22230571)
1. Engineering knottins as novel binding agents.
Moore SJ; Cochran JR
Methods Enzymol; 2012; 503():223-51. PubMed ID: 22230571
[TBL] [Abstract][Full Text] [Related]
2. Alternative binding proteins: biological activity and therapeutic potential of cystine-knot miniproteins.
Kolmar H
FEBS J; 2008 Jun; 275(11):2684-90. PubMed ID: 18435757
[TBL] [Abstract][Full Text] [Related]
3. Biological diversity and therapeutic potential of natural and engineered cystine knot miniproteins.
Kolmar H
Curr Opin Pharmacol; 2009 Oct; 9(5):608-14. PubMed ID: 19523876
[TBL] [Abstract][Full Text] [Related]
4. Synthetic Cystine-Knot Miniproteins - Valuable Scaffolds for Polypeptide Engineering.
Avrutina O
Adv Exp Med Biol; 2016; 917():121-44. PubMed ID: 27236555
[TBL] [Abstract][Full Text] [Related]
5. Engineered knottin peptides as diagnostics, therapeutics, and drug delivery vehicles.
Kintzing JR; Cochran JR
Curr Opin Chem Biol; 2016 Oct; 34():143-150. PubMed ID: 27642714
[TBL] [Abstract][Full Text] [Related]
6. Peptide discovery using bacterial display and flow cytometry.
Getz JA; Schoep TD; Daugherty PS
Methods Enzymol; 2012; 503():75-97. PubMed ID: 22230566
[TBL] [Abstract][Full Text] [Related]
7. Engineering agatoxin, a cystine-knot peptide from spider venom, as a molecular probe for in vivo tumor imaging.
Moore SJ; Leung CL; Norton HK; Cochran JR
PLoS One; 2013; 8(4):e60498. PubMed ID: 23573262
[TBL] [Abstract][Full Text] [Related]
8. Designed ankyrin repeat proteins (DARPins) from research to therapy.
Tamaskovic R; Simon M; Stefan N; Schwill M; Plückthun A
Methods Enzymol; 2012; 503():101-34. PubMed ID: 22230567
[TBL] [Abstract][Full Text] [Related]
9. Cystine-knot peptides: emerging tools for cancer imaging and therapy.
Ackerman SE; Currier NV; Bergen JM; Cochran JR
Expert Rev Proteomics; 2014 Oct; 11(5):561-72. PubMed ID: 25163524
[TBL] [Abstract][Full Text] [Related]
10. Directed evolution of soluble single-chain human class II MHC molecules.
Esteban O; Zhao H
J Mol Biol; 2004 Jun; 340(1):81-95. PubMed ID: 15184024
[TBL] [Abstract][Full Text] [Related]
11. Replacing antibodies: engineering new binding proteins.
Banta S; Dooley K; Shur O
Annu Rev Biomed Eng; 2013; 15():93-113. PubMed ID: 23642248
[TBL] [Abstract][Full Text] [Related]
12. Molecular evolution of cystine-stabilized miniproteins as stable proteinaceous binders.
Chang HJ; Hsu HJ; Chang CF; Peng HP; Sun YK; Yu HM; Shih HC; Song CY; Lin YT; Chen CC; Wang CH; Yang AS
Structure; 2009 Apr; 17(4):620-31. PubMed ID: 19368895
[TBL] [Abstract][Full Text] [Related]
13. Affilin-novel binding molecules based on human gamma-B-crystallin, an all beta-sheet protein.
Ebersbach H; Fiedler E; Scheuermann T; Fiedler M; Stubbs MT; Reimann C; Proetzel G; Rudolph R; Fiedler U
J Mol Biol; 2007 Sep; 372(1):172-85. PubMed ID: 17628592
[TBL] [Abstract][Full Text] [Related]
14. Small binding proteins selected from a combinatorial repertoire of knottins displayed on phage.
Smith GP; Patel SU; Windass JD; Thornton JM; Winter G; Griffiths AD
J Mol Biol; 1998 Mar; 277(2):317-32. PubMed ID: 9514763
[TBL] [Abstract][Full Text] [Related]
15. Targeting the tumor vasculature with engineered cystine-knot miniproteins.
Lui BG; Salomon N; Wüstehube-Lausch J; Daneschdar M; Schmoldt HU; Türeci Ö; Sahin U
Nat Commun; 2020 Jan; 11(1):295. PubMed ID: 31941901
[TBL] [Abstract][Full Text] [Related]
16. T cell receptor engineering.
Stone JD; Chervin AS; Aggen DH; Kranz DM
Methods Enzymol; 2012; 503():189-222. PubMed ID: 22230570
[TBL] [Abstract][Full Text] [Related]
17. Optimizing structural modeling for a specific protein scaffold: knottins or inhibitor cystine knots.
Gracy J; Chiche L
BMC Bioinformatics; 2010 Oct; 11():535. PubMed ID: 21029427
[TBL] [Abstract][Full Text] [Related]
18. Natural and engineered cystine knot miniproteins for diagnostic and therapeutic applications.
Kolmar H
Curr Pharm Des; 2011 Dec; 17(38):4329-36. PubMed ID: 22204431
[TBL] [Abstract][Full Text] [Related]
19. Chemical synthesis, backbone cyclization and oxidative folding of cystine-knot peptides: promising scaffolds for applications in drug design.
Reinwarth M; Nasu D; Kolmar H; Avrutina O
Molecules; 2012 Oct; 17(11):12533-52. PubMed ID: 23095896
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and MALDI-TOF Mass Spectrometric Characterization of a Novel Native and Recombinant Cystine Knot Miniprotein from Solanum tuberosum subsp. andigenum cv. Churqueña.
Cotabarren J; Tellechea ME; Tanco SM; Lorenzo J; Garcia-Pardo J; Avilés FX; Obregón WD
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
